ITCI - Intra-Cellular Therapies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5696.35M
Enterprise Value 3443.1M
Trailing P/E N/A
Forward P/E 1-4.22
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.41
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.74

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.66%
Return on Equity (ttm)-43.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-132.17M
EBITDA -161.49M
Net Income Avi to Common (ttm)-154.48M
Diluted EPS (ttm)-2.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)312.82M
Total Cash Per Share (mrq)5.67
Total Debt (mrq)23.73M
Total Debt/Equity (mrq)8.22
Current Ratio (mrq)9.59
Book Value Per Share (mrq)5.24

Cash Flow Statement

Operating Cash Flow (ttm)-126.81M
Levered Free Cash Flow (ttm)-73.78M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.55
52-Week Change 3-28.02%
S&P500 52-Week Change 38.59%
52 Week High 323.62
52 Week Low 310.21
50-Day Moving Average 312.71
200-Day Moving Average 312.79

Share Statistics

Avg Vol (3 month) 3384.11k
Avg Vol (10 day) 3799.3k
Shares Outstanding 555.13M
Float 45.76M
% Held by Insiders 112.40%
% Held by Institutions 178.69%
Shares Short (May 31, 2019) 44.24M
Short Ratio (May 31, 2019) 412.55
Short % of Float (May 31, 2019) 411.07%
Short % of Shares Outstanding (May 31, 2019) 47.70%
Shares Short (prior month Apr 30, 2019) 43.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A